Contact this trialFirst, we need to learn more about you.
NK1 Receptor Antagonist
Anti-Nausea Medication for Breast Cancer
Recruiting1 awardPhase 3
Urbana, Illinois
This trial will compare netupitant/palonosetron hydrochloride and dexamethasone with prochlorperazine or olanzapine to see if they are more effective in improving chemotherapy-induced nausea and vomiting in patients with breast cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.